Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX)
VRTX Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
15%
Analyst Rating:
BUY
Analyst Forecast (1yr):
13%
VRTX Stock Analysis
VRTX
PE Ratio:
25.4
VRTX
PEG Ratio:
2.1
VRTX
Forward EPS Growth (12 month):
12.30%
VRTX
PS Ratio:
8.9
VRTX
PSG Ratio:
0.9
VRTX
Forward Revenue Growth (12 month):
9.90%
VRTX Articles
No data was found